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Fusion of the viral and host cell membranes is a necessary first step for infection by enveloped viruses and is
mediated by the envelope glycoprotein. The transmembrane subunits from the structurally defined “class I”
glycoproteins adopt an α-helical “trimer-of-hairpins” conformation during the fusion pathway. Here, we present
our studies on the envelope glycoprotein transmembrane subunit, GP2, of the CAS virus (CASV). CASV was
recently identified from annulated tree boas (Corallus annulatus) with inclusion body disease and is implicated
in the disease etiology. We have generated and characterized two protein constructs consisting of the
predicted CASV GP2 core domain. The crystal structure of the CASV GP2 post-fusion conformation indicates
a trimeric α-helical bundle that is highly similar to those of Ebola virus and Marburg virus GP2 despite CASV
genome homology to arenaviruses. Denaturation studies demonstrate that the stability of CASV GP2 is pH
dependent with higher stability at lower pH; we propose that this behavior is due to a network of interactions
among acidic residues that would destabilize the α-helical bundle under conditions where the side chains are
deprotonated. The pH-dependent stability of the post-fusion structure has been observed in Ebola virus and
Marburg virus GP2, as well as other viruses that enter via the endosome. Infection experiments with CASV
and the related Golden Gate virus support a mechanism of entry that requires endosomal acidification. Our
results suggest that, despite being primarily arenavirus like, the transmembrane subunit of CASV is extremely
similar to the filoviruses.
© 2013 Elsevier Ltd. All rights reserved.Introduction
Infection by enveloped viruses, whose infectious
particles are surrounded by a lipid bilayer, requires
fusion of the host cell and viral membranes; this
process is facilitated by one or more viral envelope
glycoproteins [1]. Although details of this mechanism
vary among viruses, viral glycoproteins typically
consist of a surface subunit, which binds to a host
cell receptor, and a transmembrane subunit respon-
sible for drawing host and viral membranes togetheratter © 2013 Elsevier Ltd. All rights reservevia the formation of a stable post-fusion conforma-
tion [2]. The “class I” viral fusion proteins, which
include those of the human immunodeficiency
viruses, influenza, Ebola viruses [exemplified by
Ebola virus (EBOV) and Sudan virus (SUDV)] and
Marburg virus (MARV), are defined by the formation
of a core, trimeric α-helical bundle by the ectodomain
of the transmembrane subunit during membrane
fusion [1,3]. The post-fusion conformations consist
of a “trimer-of-hairpins” motif in which the ectodo-
main N- and C-terminal segments are folded backd. J. Mol. Biol. (2014) 426, 1452–1468
1453Characterization of the CASV Glycoprotein GP2 Core Domainonto one another; this configuration draws the two
membranes into proximity and the energy gained
from refolding provides the driving force for mem-
brane fusion. Here, we report the crystal structure of
the transmembrane subunit, GP2, from the CAS
virus (CASV). CASV was recently isolated from
captive boid snakes with inclusion body disease
(IBD) and is a putative causative agent [4]. Although
CASV is primarily arenavirus like, with a similar
genomic organization and a homologous nucleopro-
tein and RNA polymerase, its envelope glycoprotein
is more similar to those of EBOV, SUDV and MARV.
EBOV, SUDV and MARV belong to the family
Filoviridae (filoviruses) of enveloped, negative-strand
RNA viruses [5,6]. These are important human
pathogens that cause severe hemorrhagic fever
associated with high mortality rates [7]. Viral entry
has been extensively characterized for EBOV and is
mediated by its envelope glycoprotein, GP, which is
composed of trimers of GP1–GP2 heterodimers [8].
Entry is initiated by GP1 binding to cell surface
receptors that trigger viral uptake into the endocytic
pathway [9,10]. Within endosomes, GP is cleaved by
host cysteine proteases, including cathepsin B and
cathepsin L, which cleave GP1 to remove all but an
~17-kDa N-terminal fragment [11]. Interaction of this
fragment with the viral receptor Niemann-Pick C1
cholesterol transporter [12–14] initiates the fusion
reaction, whereby GP2 undergoes a large-scale
conformational change resulting in the insertion of a
hydrophobic fusion peptide into the host cell mem-
brane. This conformation, where GP2 spans the host
and viral membranes, is referred to as the “extended”
or “pre-hairpin” intermediate. Next, the N-terminal
heptad repeat (NHR) and the C-terminal heptad
repeat (CHR) regions of GP2 fold into a thermostable
six-helix bundle, or “trimer-of-hairpins”, promoting
membrane fusion by bringing the two membranes
into proximity and inducing lipid mixing of the outer
leaflets [3,15].
Members of the family Arenaviridae of enveloped
viruses with ambisense single-strand RNA genomes
(arenaviruses) are also known to cause significant
human disease. There are currently 25 arenavirus
species recognized by the International Committee
for Taxonomy of Viruses, over 30% of which contain
members that are known to infect humans [16,17].
These species can be delineated into two groups
based on their antigenic properties and geographic
location: the Old World viruses, most notably the
lymphocytic choriomeningitis virus (LCMV) and
Lassa virus (LASV), and the New World viruses
[16,17]. Multiple Old and New World arenaviruses,
including LASV, and a number of the new world
viruses cause severe hemorrhagic fevers in humans
associated with significant morbidity and mortality
[17]. LCMV is endemic in Mus musculus (the
common house mouse) worldwide; although LCMV
generally causes a mild viral syndrome in immuno-competent persons, infection has been associated
with meningitis, encephalitis and, sometimes, death
in immunocompromised patients and with severe
birth defects and mental retardation in congenital
infection [18–23].
Until recently, all arenaviruses have been tightly
linked to rodent hosts as their primary reservoir [24].
Documented human infection has occurred through
exposure to infected animals, either by direct contact
of compromised skin with infectious materials or
through mucosal exposure to aerosolized viral parti-
cles. Recently, however, Stenglein et al. identified
CASV and two other novel arenavirus-like agents in
boid snakes with IBD [4]. This condition is character-
ized symptomatically by neurological abnormalities,
regurgitation and secondary infections and histolog-
ically by cellular eosinophilic inclusions [4,25]. These
novel viruses, CASV, the Golden Gate virus (GGV)
andCollierville virus, represent the first arenavirus-like
viruses to be identified in a reptilian species and
suggest that the species tropism of the Arenaviridae
family may be much broader than previously thought.
Indeed, additional variants of these arenavirus-like
viruses have subsequently been identified in boid
snakeswith IBD in the Netherlands [26] and in Finland
[27], suggesting that such viruses may be present in
snakes worldwide.
In the CASV GP2 post-fusion structure reported
here, the overall backbone conformation of CASV
GP2 is highly similar to those of EBOV and MARV
GP2. Previous studies have shown that both EBOV
and MARV GP2 post-fusion bundles exhibit a
marked pH-dependent stability, with higher thermal
and chemical stability observed at lower pH [28–30].
It is hypothesized that this feature of the post-fusion
α-helical bundle is reflective of the endosomal
mechanism of entry for these viruses; stabilization of
conformations required for membrane fusion (e.g., the
post-fusion six-helix bundle) is promoted under
conditions of appropriate cellular compartments.
Similar pH-dependent stability was observed for
CASV GP2. Infectivity experiments using CASV and
GGV in the presence of chemical inhibitors of
endosomal acidification support the hypothesis
that endosomal acidification is required for entry.
This work is the first structural characterization of a
membrane glycoprotein from this newly identified
group of viruses.Results
Protein design
Alignment of GP2 sequences from CASV and
related boid snake viruses with those of EBOV,
SUDV and MARV suggests that the core domain
consists of residues ~254–351 (CASV numbering;
254   267        277        287
|             |          | *        |  
                                      a  d    a  d   a   d   a  d    a  d    a  d   d    a  d   a 
pIICASV-GP2(267-351): MHHHHHHENL YFQGNMKQIE DKIEEILSKI YHIENEIARI KKLIGAIASK IIKTANYTTN ALFLLNKEES
CASV-GP2(254-351)   : MHHHHHHENL YFQGN NSLQISEI EHVTDAIASK IIKTANYTTN ALFLLNKEES
GGV GP2             :                                    NSLQISQL EHVTDAIACK IAKTSNYTTT ALFLLNKEEG
Boa Av NL B3 GP2    :                                    NSLQISQL EHVTDAIACK IAKTSNYTTT ALFLLNKEEG
MARV GP2 :                                                  NLVCR LRRLANQTAK SLELLLRVTT
SUDV GP2   :                                                  ALVCG LRQLANETTQ ALQLFLRATT
EBOV GP2 : GLICG LRQLANETTQ ALQLFLRATT
a  d   d    a  d   a 
| | *        |
553        563        573
                           297        307        317        327        337        347
|          |          |          |          |          |
                       d   a  d    a  d   a   d   a
pIICASV-GP2(267-351): EIRDHVVEHE LALNYLLAHQ GGLCNVVKGP MCSSDIDDFS KNVSDMIDKV HEEMKKFYHE
CASV-GP2(254-351)   : EIRDHVVEHE LALNYLLAHQ GGLCNVVKGP MCSSDIDDFS KNVSDMIDKV HEEMKKFYHE
GGV GP2             : EIRDHVIEHE VALNYLLAHQ GGLCSVVKGP MCCSDIDDFR RNVSDMIDKV HEEMKKFYHE
Boa Av NL B3 GP2    : EIRDHVIEHE IALNYLLAHQ GGLCNIVKGP MCCSDIDDFR RNVSDMIDRV HEEMKKFYHE
MARV GP2            : EERTFSLINR HAIDFLLTRW GGTCKVL-GP DCCIGIEDLS KNISEQIDQI KKDEQK
SUDV GP2   : ELRTYTILNR KAIDFLLRRW GGTCRIL-GP DCCIEPHDWT KNITDKINQI IHDFI
EBOV GP2 : ELRTFSILNR KAIDFLLQRW GGTCHIL-GP DCCIEPHDWT KNITDKIDQI IHDFV
                       d   a  d    a  d   a   d   a 
                           |          |          |          |          |        
583        593        603        612        622      
His Tag NHRGCN4pIITEV
NHR CHR
Fig. 1. CASV GP2 protein design. The sequences of the CASV GP2 constructs [pIICASV-GP2(267–351) and
CASV-GP2(254–351)] are shown in alignment to the sequences of EBOV, SUDV, MARV, GGV and Boa Av NL B3 GP2.
Segments corresponding to α-helical segments for the previously reported EBOV GP2 and MARV GP2 structures, as well
as for the pIICASV-GP2(267–351) structure, are represented as colored cylinders, with the colors of the cylinders
matching the structural elements depicted in Fig. 5a for the pIICASV-GP2(267–351) structure. The numbering for the
EBOV GP2 residues is shown below the sequences; the numbering for the CASV GP2 residues is shown above the
sequences. The a and d positions for the heptad repeat are indicated for the NHR region, with the heptad repeat stutter
residue (T565 in EBOV; T279 in CASV) indicated with asterisks. The GCN4 pII segment is shown for pIICASV-GP2(267–
351) (cyan-colored cylinder).
1454 Characterization of the CASV Glycoprotein GP2 Core DomainFig. 1). Based on this sequence comparison, we
prepared two protein constructs: one consisting of
CASV GP2 residues 254–351 [“CASV-GP2(254–
351)”] and another one consisting of residues
267–351 containing an N-terminal fusion to a trimeric
var iant of GCN4 coi led coi l (“pII” ) [ “pII-
CASV-GP2(267–351)”]. The shortened CASV seg-
ment in pIICASV-GP2(267–351) was predicted
based on the boundary of the α-helical NHR
segment in EBOV and MARV GP2 [3,15,30]. The
pII GCN4 coiled coil contains isoleucine side chains
at the core heptad repeat positions (a and d of the
canonical abcdefg repeat) that designate preferen-
tial homotrimer formation [31,32]. Chimeras of pII
and other trimeric coiled coils with fragments of class
I fusion protein enhance solubility and have facilitat-
ed structural studies in the absence of the trans-
membrane segment in some cases [15,30]. In both
CASV GP2 constructs, the cysteines at positions
270 and 324 were mutated to serine. The corre-
sponding residues in filovirus GP2 form disulfide
bonds within the fusion loop (C270) and to the GP1
subunit (C324), both of which were omitted from the
core domain construct. Cysteines 315 and 323 were
left as native identity, as the corresponding residuesform an intramolecular disulfide bond that stabilizes
the loop regions of EBOV and MARV GP2 core
domains [3,15,30].
A heptad repeat stutter is predicted in the CASV
GP2 NHR region at T279, by analogy to stutters
found at corresponding positions of EBOV and
MARV GP2 [15,30]. Heptad repeat stutters result
from a disruption in the heptad repeat pattern caused
by insertion of an additional defg segment (abcdefg
defgabc). The stutters in the EBOV and MARV
GP2 NHR segment cause a distortion of the NHR
α-helix at the stutter position and a slight local
unwinding of the triple-stranded superhelix. For
pIICASV-GP2(267–351), the pII segment was engi-
neered to maintain registry of the heptad repeat
pattern with the N-terminal segment of the NHR
α-helix, thereby accounting for effects of the stutter
on hydrophobic periodicity (Fig. 1). Notably, heptad
stutters are found in a number of viral glycoproteins
from both class I (α-helical) and class III (mixed α/β
structure) categories and have been hypothesized to
play a role in viral entry because of this conservation
across phylogenetically distant species [33]. How-
ever, the precise mechanistic role of the heptad
repeat stutter in viral fusion remains unknown.
0.00 5.00 10.00 15.00 20.00 25.00 30.00
Trimer
(45 kDa)
Dimer
(30 kDa)
Monomer
(15 kDa)
(a)
(b)
Fig. 2. Glutaraldehyde cross-linking and FPLC analysis of CASV GP2 constructs. (a) Glutaraldehyde cross-linking gel
with CASV-GP2(254–351). Bands were observed at 13 kDa, 26 kDa and 39 kDa, corresponding to monomer, dimer and
trimer. The band intensity shifts from monomer to trimer with increasing reaction time. (b) FPLC size-exclusion
chromatography trace for pIICASV-GP2(267–351). The observed molecular mass estimate is 45.1 kDa. Expected elution
volumes for the monomer, dimer and trimer are indicated.
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an N-terminal hexahistidine tag, for purification
purposes, separated from the rest of the sequence
by the tobacco etch virus protease cleavage
sequence (~ENLYFQG~). CASV-GP2(254–351)
and pIICASV-GP2(267–351) were expressed in
Escherichia coli BL21(DE3) cells. The proteins
were purified by nickel-affinity chromatography and
reverse-phase high-performance liquid chromatog-
raphy; refolding was achieved by stepwise dialysis.
Solution characterization of CASV-GP2(254–
351) and pIICASV-GP2(267–351)
All class I viral fusion proteins that have been
biochemically characterized exist as trimers in their
fusion-active state [1,2]. Glutaraldehyde cross-link-
ing experiments with CASV-GP2(254–351) revealedbands with molecular masses corresponding to
monomer (13 kDa), dimer (26 kDa) and trimer
(39 kDa) (Fig. 2a). The band intensity shifted from
the monomer to the trimer with increasing reaction
time. Additionally, gel-filtration analysis by FPLC (fast
p ro te in l iqu id chromatography) wi th pI I -
CASV-GP2(267–351) (with an expected molecular
mass for a trimer of 45.4 kDa) revealed an observed
molecular mass of 45.1 kDa (Fig. 2b). These data
indicate that CASV-GP2(254–351) and pIICASV-
GP2(254–351) exist as trimers in solution.
Circular dichroism (CD) indicates that both
CASV-GP2(254–351) and pIICASV-GP2(267–351)
are α-helical, with double minima observed at 208
and 222 nm in 10 mM sodium acetate (pH 4.1–6.5).
However, the quaternary packing of the α-helices
varies with pH for both CASV GP2 constructs, as
indicated by the shifted signal intensity and the ratio
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Fig. 3. Full-wavelength CD scans. CD spectra of CASV-GP2(254–351) (a) and pIICASV-GP2(267–351) (b) in 10 mM
sodium acetate (pH 4.1–7.0).
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conditions (Fig. 3). Thermal denaturation revealed
a significant pH dependence of thermal stability forFr
ac
tio
n 
Un
fo
ld
ed
 (F
u
n
f)
0 20 40 60 80 100
0.0
0.2
0.4
0.6
0.8
1.0
Temperature (°C)
Fr
ac
tio
n 
Un
fo
ld
ed
 (F
u
n
f)
pH 4.1
pH 4.8
pH 5.3
pH 5.8
pH 6.0
pH 6.3
(a) (b
(c) (d
0 20 40 60 80 100
-30000
-20000
-10000
0
Temperature (°C)
pH 6.0
pH 5.3
pH 4.1
[θ 2
22
] (
de
g c
m2
 
dm
ol
-
1 )
Fig. 4. Thermal stability of CASV-GP2(254–351) and pIICAS
ellipticity at 222 nm. Thermal denaturation curves of CASV-GP
sodium acetate at varying pH values. (c) Thermal denaturation
(pH 4.1, 5.3 and 6.0 in the presence of 500 mM NaCl). (d)
C323S) in 10 mM sodium acetate (pH 4.1, 5.3 and 6.0). Thermboth constructs. The thermal midpoint (Tm) of
CASV-GP2(254–351) was 82.9 ± 0.7 °C at pH 4.1
but was significantly lower (~30 °C) at pH 6.3 (Fig. 40.0
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Thermal denaturation curves of pIICASV-GP2(267–351;
al midpoints (Tm values) are provided in Table 1.
Table 1. Melting temperatures for CASV GP2 constructs
Buffering condition Tm (°C)
a
CASV-GP2(254–351)
10 mM sodium acetate, pH 4.1 82.9 ± 0.7
10 mM sodium acetate, pH 4.8 72.3 ± 0.7
10 mM sodium acetate, pH 5.3 49.0 ± 0.1
10 mM sodium acetate, pH 5.8 25.1 ± 3.7
10 mM sodium acetate, pH 6.0 ~35 (ambiguous fit)
10 mM sodium acetate, pH 6.3 ~30 (ambiguous fit)
pIICASV-GP2(267–351)
10 mM sodium acetate, pH 4.1 ~99 (ambiguous fit)
10 mM sodium acetate, pH 4.8 ~97 (ambiguous fit)
10 mM sodium acetate, pH 5.3 91.0 ± 1.3
10 mM sodium acetate, pH 6.0 ~40 (ambiguous fit)
10 mM sodium acetate, pH 6.3 ~35 (ambiguous fit)
pIICASV-GP2(267–351; C323S)
10 mM sodium acetate, pH 4.1 ~100 (ambiguous fit)
10 mM sodium acetate, pH 5.3 90.8 ± 0.1
10 mM sodium acetate, pH 6.0 40.9 ± 0.1
a Errors listed here represent 95% confidence intervals from the
data fitting.
1457Characterization of the CASV Glycoprotein GP2 Core Domainand Table 1). The overall thermal stability of
pIICASV-GP2(267–351) was higher, as expected
due to the contribution from the pII segment, but the
general pH-dependent trend in thermal stability was
still apparent. At pH 4.1, pIICASV-GP2(267–351)
could not be fully unfolded even at ~100 °C, but at
pH 6.3, the melting temperature was ~35 °C (Fig. 4
and Table 1). Above pH 6.5, both proteins were
observed to precipitate out of solution. We have
previously observed such pH-dependent behavior
for both EBOV and MARV GP2 [28–30]. The
pH-dependent stability of CASV GP2 follows the
same pattern as observed with filovirus GP but is
significantly more pronounced with CASV GP2
showing marked instability at pH values above
pH ~ 5.3 and protein precipitation above pH 6.5.
Addition of 500 mM salt (NaCl) resulted in an
unusual pattern of thermal denaturation, with a
biphasic melting profile (Fig. 4c); 500 mM NaCl
appears to stabilize the bundle at pH 4.1, 5.3 and
6.0, but pH-dependent stability is still observed.
Dependence of CASV and GGV entry on
endosomal pH
We hypothesized that CASV enters host cells
through the endocytic pathway because of the
observed pH-dependent stability of the CASV GP2
post-fusion conformation. We performed two types
of experiments to test this hypothesis. First, we
quantified virus particle production from infected
cells by measuring supernatant viral RNA levels by
quantitative real-time PCR (Fig. 5). We used CASV
and the distantly related GGV that was identified
along with CASV in annulated tree boas with IBD to
perform these experiments. CASV and GGV share~50% overall pairwise amino acid identity [4].
Pretreatment of JK cells (derived from boa constric-
tor) with monensin, a lysosomotropic ionophore,
decreased GGV production by ~20- to 40-fold and
CASV production by ~1000-fold. Pretreatment with
bafilomycin A1 (Baf A1), a specific inhibitor of the
vacuolar proton pump, had an even more dramatic
effect, reducing production of both viruses by
approximately 4 logs (Fig. 5a). We also measured
the infectivity of individual GGV particles in a
fluorescent-focus assay, which reflects the virus
titer and the probability that an individual particle
will initiate a productive infection under the exper-
imental conditions (Fig. 5b). Note that we were
unable to perform the fluorescent-focus assay
using CASV due to a lack of suitable antibody
reagents. Treatment of JK cells with Baf A1
reduced the number of GGV focus-forming units
by ~65-fold (Fig. 5c). The results of these exper-
iments suggest that an acidic endosomal environ-
ment is necessary for efficient infectivity by CASV
and GGV.
Crystal structure of pIICASV-GP2(267–351)
pIICASV-GP2(267–351) crystallized readily, with
the best crystals diffracting to 2.0 Å. The MARV GP2
post-fusion structure (PDB ID 4G2K) was used as a
molecular replacement model [30]. Initially, diffrac-
tion data were processed in rhombohedral (R3)
space group, with one chain per asymmetric unit, but
it soon became apparent that crystals demonstrate
strong pseudo-symmetry. The structure was then
solved and refined in monoclinic (C2) space group
(Table 2), revealing a trimer of pIICASV-GP2(267–
351) chains in the asymmetric unit. However,
electron density in the loop areas was not interpret-
able, even though the rest of the structure was well
defined. Only refinement in the lowest symmetry
triclinic (P1) space group, with two trimers per
asymmetric unit, produced traceable electron densi-
ty within the loop areas (Table 2 and Fig. 6c). This
conformational variability might be due partial
disulfide bond formation between C315 and C323.
The overall architecture of pIICASV-GP2(267–
351) is a trimeric coiled coil, spanning approximately
122 Å, ~55 Å of which corresponds to the pII
coiled-coil segment (Fig. 6). T279, the predicted
heptad repeat stutter position, points inward toward
the core of the helical bundle. There are no breaks in
the α-helical periodicity from the pII segment to the
CASVGP2 bundle, indicating that a stutter is present
in CASV GP2 as predicted. The NHR segments of
CASV form the center of the bundle, while the CHR
segments pack along the outside of the bundle,
spanning approximately 50% of the total CASV GP2
trimer length. The NHR and CHR segments are
separated by a loop region: the polypeptide chain
undergoes a sharp turn at residue H310 to reverse
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Fig. 5. CASV and GGV infectivity requires an acidic endosomal environment. (a) Chemical inhibitors of endosomal
acidification decrease CASV and GGV production. Quantification of supernatant viral RNA levels following treatment
with indicated drugs. The mean and standard deviation of duplicate experiments is shown. (b) Fluorescent-focus assay.
Serial dilutions of GGV were used to inoculate monolayers of JK cells, which were covered with agarose overlays
to prevent diffusion. After 7 days of incubation, foci of infection were stained with anti-GGV-NP antibody and counted.
(c) Quantification of fluorescent-focus assays. The mean and standard deviation of duplicate experiments is shown.
1458 Characterization of the CASV Glycoprotein GP2 Core Domaindirection at the membrane-distal side and lead into
the helix–turn–helix motif that precedes the CHR
α-helix. However, significant portions of this inter-
vening segment had poorly resolved electron
density.
In MARV GP2, the pH-dependent stability is
primarily the result of specific anion–anion (AniAni)
interactions that destabilize the post-fusion confor-
mation. A “stripe” of acidic residues is present at the
center of the post-fusion structure, consisting of both
core (E580) and surface-exposed (E579 and E614)
positions. Presumably, these residues are deproto-
nated at neutral pH, resulting in unfavorable inter-
actions between anionic side chains and significant
density of local negative charge that destabilizes
the post-fusion structure. Under low pH conditions,
however, these residue side chains would beprotonated forming the conjugate acid, thereby
alleviating such repulsive interactions. AniAni inter-
actions were implicated in pH-dependent behavior of
designed proteins containing shorter segments from
the EBOV GP2 core domain, though these residues
were found mostly at the surface of the six-helix
bundle [28].
CASV GP2 has a high anionic character, contain-
ing seven glutamic acid residues and six aspartic
acid residues per monomeric chain (21 glutamic
acids and 18 aspartic acids per trimer) (Fig. 7). A
large number of these anionic residues are concen-
trated in membrane-distal half of the α-helical
bundle, separate from the NHR–CHR helical pack-
ing region. Several of the anionic residues in CASV
form a stripe at the midsection of the CASV GP2
bundle, analogous to the anion stripe from MARV
Table 2. Data collection and refinement statistics for the
pIICASV-GP2(254–351) crystal structure
PDB 4N23 4N21
Data collection
Wavelength (Å) 0.9791 0.9791
Space group C2 P1
Unit cell dimensions
a (Å) 80.87 46.68
b (Å) 46.72 46.71
c (Å) 109.47 109.45
α, β (°) 90, 104.28 102.32, 89.99
γ (°) 90 119.98
Resolution range (Å) 20.0-2.0 20.0-2.0
Observed reflections 100,037 102,320
Unique reflections 27,014 51,572
Completeness (%)a 99.8 (99.9) 97.7 (96.9)
Rmerge (I)
b 0.072 (0.491) 0.059 (0.447)
I/σI 11.1 (3.0) 11.0 (2.9)
Structure refinement
Rcryst (%)
c 0.176 0.168
Rfree (%)
c 0.228 0.212
Protein nonhydrogen atoms 3017 6057
Water molecules 131 232
Average B-factor (Å2) 52.4 53.9
RMSD values from ideal value
Bonds (Å) 0.009 0.009
Angles (°) 1.12 1.14
Torsion angles (°) 17.5 17.2
a Values in parentheses indicate statistics for the high-resolution
bin (2.05–1.99 Å).
b Rmerge = ∑∑j|Ij(hkl) − 〈I(hkl )〉|/SSj|〈I(hkl )〉|, where Ij is the
intensity measurement for reflection j and 〈I 〉 is the mean
intensity over j reflections.
c Rcryst/(Rfree) = ∑||Fo(hkl )| − |Fc(hkl )||/S|Fo(hkl )|, where Fo
and Fc are observed and calculated structure factors,
respectively. No s-cutoff was applied. We excluded 5% of the
reflections from refinement and used them to calculate Rfree.
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consists of residues E289, E290, E292 and D328.
The electron density for these residues is well
defined (Fig. 6b) and strongly supports the modeled
side-chain orientation of these residues directly
toward one another in close proximity. The high
density of acidic residues results in pronounced
negative electrostatic surface potential in this region
of the protein (Fig. 9). The distances between these
residues are as follows: E289 Oδ from Chain A to
E290 Oδ from Chain C, 3.62 Å; E290 Oδ from Chain
A to E289 Oδ from Chain B, 3.24 Å; E292 Oδ from
Chain A to D328 Oγ from Chain C, 2.53 Å; D328 Oγ
from Chain A to E292 Oδ from Chain B, 2.70 Å.
It is likely that deprotonation causes unfavorable
repulsions among the anionic residues and contrib-
utes to the dramatic pH-dependent stability of CASV
GP2. Of note, the anion stripes in the CASV and
MARV GP2 bundles are located in similar regions, at
about the mid-section of the NHR core trimer (Fig. 8).
Interestingly, the MARV GP2 anion stripe includes a
core d residue, MARV E580, whereas the CASV
GP2 anion stripe contains a core a residue, CASVE290. Therefore, the core residues of the CASVGP2
anion stripe are located ~1 α-helical turn closer to
the N-terminus of the protein (Fig. 8). As a result, the
E580 in MARV GP2 points almost directly into the
core NHR trimer, whereas E290 in CASV GP2 is
oriented toward the adjacent NHR α-helical axis.
This contrast in side-chain orientation reflects the
non-equivalent projection of the Cα–Cβ bond vector
relative to the α-helical axis for a and d residues in
trimeric coiled coils [32]. While this difference in a
and d positions has a strong influence on coiled-coil
topology for hydrophobic residues [31,32], it is
interesting to note that, for electrostatic effects,
they have similar functional consequences. While
the core acidic residues differ between CASV and
MARV GP2, the surface residues of the two anion
stripes are located at the same level within the coiled
coils and are nearly superimposable (Fig. 8). These
features highlight the conservation of this structural
mechanism for pH-dependent stability between
CASV and MARV GP2.
A cluster of residues exists surrounding the anion
stripe in CASV, consisting of E299, H296 and H300
from one chain and E301 from the neighboring
chain. The electron density for these residues is well
defined. H300 is modeled in a single conformation,
with the N1 atom directed toward E301conformation,
with the with the N1 atom directed toward E301 Oδ
from the neighboring chain. H296 is modeled with
two side-chain orientations, one of which is directed
toward E299 and E301. When the histidine residues
are protonated, presumably below pH 6.0, they may
act as counterions to balance the negative charge
from the two glutamic acid residues. However, once
the histidines become deprotonated at higher pH,
this counterion effect would be removed, destabiliz-
ing the protein.
Anion binding pockets have been observed in a
number of other viral GP2 proteins, but no anion
binding pocket was observed in the CASV GP2 helical
bundle.Chloride ionsarebound toasparagine residues
at the NHR trimer core in the EBOVGP2, MARV GP2,
Moloney murine leukemia virus (MoMLV) GP2 and
LCMV GP2 bundles at N586, N587, N71 and N325,
respectively [3,15,30,33,34]. There are no asparagine
residues pointed toward the internal core of CASV
GP2, which is likely why no anion is bound. At CASV
position 300, which corresponds to N586 in EBOV and
N587 in MARV, there is a histidine residue. This H300
is conserved in GGV and Boa Av NL B2 GP2 as well
(Fig. 1). The anion binding pocket to stabilize the other
α-helical bundles [35] and the absence of the bound
anion in CASV GP2 may contribute to this bundle's
relative instability at higher pH.
Disulfide bondswithin the loop region of CASVGP2
In EBOV and MARV GP2, the unstructured loop
region is stabilized by an intrachain disulfide bond
pIIGCN4
CHR
NHR
Loop
(a) (b)
E290
E290
E290
E289
E289
E289
E292
E292
E292
D328
D328
D328
D329
D329
D329
(c)
C315
C323
Fig. 6. CASV GP2 post-fusion bundle structure. (a) Overall depiction of the CASV GP2 post-fusion bundle fold, with the
secondary structural elements colorcoded according to the cylinders in Fig. 1. (b) Sample electron density, showing
residues that comprise the “anion stripe”: E289, E290, E292 and D328. (c) Electron density in the loop region, focused
around residues C315 and C323.
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C609 in MARV [3,15,30]. By analogy, a stabilizing
disulfide bond was predicted to form between CASV
C315 and C323; however, no such disulfide bond
was observed. Although the side chains of C315 and
C323 appear to point toward one another in the
crystal structure, the sulfur atoms are separated by
4.96 Å, twice the distance of a disulfide bond
(Fig. 6c). Residue 324, a cysteine in the native
GP2 sequence but a serine in our construct, is
modeled near C315. It is therefore possible that a
disulfide bond forms in the native protein between
C324 and C315. However, this is conjecture only, as
the electron density throughout the loop region is
poorly defined, and the side-chain orientation cannot
be definitively assigned. To explore this hypothesis,we generated an additional CASV GP2 construct,
pIICASV-GP2(267–351; C323S), that contained the
identity of wild-type cysteine side chain at positions
315 and 324 but a cysteine-to-serine mutation at
position 323. We hypothesized that, if the native
disulfide bond was between C324 and C315, then
pIICASV-GP2(267–351; C323S) would display
higher thermal stability than pIICASV-GP2(267–
351). pIICASV-GP2(267–351; C323S) was
expressed and purified, and thermal denaturation
was performed as described for pIICASV-GP2(267–
351). We observed that the Tm values for pII-
CASV-GP2(267–351; C323S) were within error of
the Tm values for pIICASV-GP2(267–351) (Fig. 4d
and Table 1). These data suggest either that a
disulfide bond is not formed in the C323S construct
D328C
E292A
E290A
D328A
E289A
E292B
E289C
Fig. 7. Anionic residues in CASV GP2 that may influence ph-dependent stability. Anionic residues (Asp and Glu) in the
CASV GP2 bundle are shown as stick representations. The inset shows a close-up view of the anion stripe, consisting of
residues E289, E290, E292, and D328.
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contribute to an increase in stability of this protein
construct.
Salt bridges that may stabilize CASV GP2
A number of interchain and intrachain salt bridges
appear to contribute to the stabilization of the CASV
GP2 post-fusion structure (Table 3). These salt
bridges are found in two clusters within the structure:
five salt bridges are found stabilizing the NHR–CHR
bundle portion of the protein, while two salt bridges
are found in the membrane-proximal half of the
bundle. Within the first cluster, salt bridges are
observed between E344 Oδ and K347 Nε, E343 Oδ
and K346 Nε and D336 Oγ and K340 Nε within a
monomer (Table 3). Additional salt bridges are seen
between neighboring monomers, consisting of res-
idues E344 and K274, as well as between E351 and
K271. The electron density for the lysine residues in
these interactions is well defined to the Nε atom, and
the majority of the residues involved in these salt
bridges are modeled in single conformations. K274
in chain B was modeled in two conformations, one of
which is not optimal for salt bridge formation
because of the orientation of its Nε atom away
from E344 Oδ. However, K274 in Chains A and C
are modeled in a single conformation with the Nε
atom directed toward E344 Oδ. D336 is alsomodeled in a double conformation, only one of
which is consistent with salt bridge formation. The
second cluster of salt bridges consists of D295 and
R294 within the same chain and D328 and K288 of
neighboring chains. The electron density for these
residues is all well defined and modeled in a single
conformation. Several possible salt bridges were
identified in the EBOV and MARV GP2 structures,
although salt bridge formation does not appear to be
a major mechanism of stabilization for filovirus GP2
[3,15,30]. Interestingly, four stabilizing salt bridges
per chain were observed in the LCMVGP2 structure,
and mutational studies have shown that these salt
bridges seem to play an important role in the
stabilization of most arenavirus GP2s [33].Discussion
CASV is a member of a newly discovered class of
arenavirus-like viruses that may be responsible for
IBD in boas and pythons. Along with GGV, Collierville
virus and similar viruses recently identified in the
Netherlands, including Boa3 Av NL [26], and in
Finland [27], these viruses represent the first arena-
virus- or filovirus-like agents to be identified outside of
a mammalian species, suggesting a previously
unrecognized reservoir for potential human and/or
mammalian pathogens. Our results are consistent
E614 
(MARV)
D328 
(CASV)
E580 (MARV)
E290 (CASV)
Fig. 8. Comparison of anion stripes between MARV and CASV. Alignment of CASV GP2 (red) with MARV GP2 (yellow)
with the residues involved in the anion stripes in both proteins represented in spacefill. Inset shows blow-up of anionic
stripes, shown in sticks. The residues in the stripe that are located on the surface of the bundles overlay quite well (top
inset). However, the internally facing residues differ by one α-helical turn (lower inset).
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bles GP2 from EBOV and MARV, with a homologous
overall backbone fold and an analogous pattern of
pH-dependent thermostability. We confirmed the
presence of a heptad repeat stutter in the coiled-coil
region of the CASV GP2 sequence, at position T279.
Such stutters have beenobserved in numerous class I
and class III viral fusion proteins, notably in viruses
that infect host cells through the endocytic pathway
[33]. Alignment of CASV, GGV and Boa3 AV NL
indicates that CASV T279 is conserved across these
three viruses (Fig. 1).
We demonstrated that an acidic endosomal
environment is necessary for efficient infectivity by
CASV and GGV. These findings are consistent with
our observations that CASV GP2 is structurally
similar to filovirus GP2. Additional experiments will
be required to more finely delineate the endocytic
pathways and cellular factors involved in CASV
entry. The JK tissue culture virus replication systems
described here provide a platform for such investi-gations. The recent sequencing of the boa constric-
tor genome will facilitate the identification of host
factors involved in entry [36].
We have identified an anion stripe, consisting of
residues E289, E290, E292 and D328, at the
mid-section of the CASV GP2 helical bundle. This
stripe is analogous to the anion stripe observed in
MARV GP2; interaction between residues in the
stripe may be responsible for the pH-dependent
stability of the CASV GP2 post-fusion bundle. These
residues are surface exposed and result in signifi-
cant negative electrostatic surface potential in this
portion of the bundle with a solvation energy of
−7175 kcal/mol, indicating that the surface of this
protein is highly charged (Fig. 9). Comparison of
the solvation energy of CASV GP2 to EBOV GP2
(−3178 kcal/mol), MARV GP2 (−4163 kcal/mol) and
LCMV GP2 (−6162 kcal/mol) suggests that CASV
GP2 contains the highest surface charge of these
four proteins (Fig. 9). Several studies have demon-
strated the importance of electrostatics in stabilizing
CASV GP2 MARV GP2 (4G2K)  EBOV GP2 (2EBO) LCMV GP2 (3MKO) 
Anion  
Stripe 
Fig. 9. Calculated electrostatic surface potential for CASV GP2, MARV GP2 (PDB ID 4G2K), EBOV GP2 (PDB ID
2EBO) and LCMV (PDB ID 3MKO). The PBEQ server was used to create the surface representations with the generic
presets and the solvent-accessible surface representation is shown with an electrostatic potential map (+15 kcal/mol of e
in blue and −15 kcal/mol of e in red).
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those that are stabilized by low pH [28,29,35,37–40].
The anion stripe found in CASV GP2 has signif-
icantly more anionic character than the analogous
MARV GP2 anion stripe. This analysis provides a
potential rationale for the pH-dependent stabilization
of CASV GP2, which is stabilized at lower pH than
either MARV GP2 or EBOV GP2 [28,29]. We
observed that 500 mM salt significantly stabilized
the bundle from pH 4.1 to pH 6.0 (Fig. 4c), presum-
ably by shielding the charges on the surface of
CASV GP2, supporting the hypothesis that the
anion stripe is at least partially responsible for the
destabilization of the bundle at higher pH.
As an interesting comparison, the post-fusion
structure of the transmembrane subunit from the
avian sarcoma leukosis virus (ASLV) envelope
glycoprotein (TM) was recently reported and sharesTable 3. Salt bridges that may stabilize the CASV GP2
post-fusion structure
Salt bridges observed in CASV GP2 post-fusion structure
Residue pairing Interatomic distances (Å)
Chain A Chain B Chain C
Glu344Oδ ↔ Lys274Nε 2.7 4.2 3.5
Glu344Oδ ↔ Lys347Nε 3.3 3.6 2.7
Glu351Oδ ↔ Lys271Nε 3.0 2.7 3.5
Glu343Oδ ↔ Lys346Nε 3.7 4.6 3.3
Asp336Oγ ↔ Lys340Nε 5.1 3.2 4.4
Asp328Oγ ↔ Lys288Nε 4.1 4.3 3.9
Asp295Oγ ↔ Arg294 guanidinium N 4.1 4.2 3.8high structural similarity to EBOV and MARV GP2
(backbone RMSD values of 1.6 and 1.5 Å, respec-
tively) [41]. ASLV enters cells using an unusual
two-step mechanism that has both pH-independent
and pH-dependent features. Receptor binding and
exposure of the fusion loop occur at neutral pH;
however, viral reverse transcripts are not detected in
cells treated with bafilomycin, suggesting that
endosomal pH is required for infection [42]. Aydin
et al. found that the ASLV TM bundle was equally
stable at low and neutral pH, with only small
differences in Tm, over a range of pH 5.0–8.5 [41].
This behavior contrasts with the marked pH-depen-
dent stability of the EBOV, MARV and CASV GP2
post-fusion α-helical bundles. Mutational studies on
ASLV TM suggest that two histidine residues (H490
and H492) in the chain reversal region confer stability
at low pH either by direct electrostatic interaction with
a neighboring acidic residue (H492 and D496) or by
overall stabilization of a putative helical dipole at
the membrane-distal end of the core NHR trimer.
No AniAni interactions were identified in ASLV TM,
consistent with the finding that the post-fusion
conformation is not sensitive to pH [41].
To compare the overall backbone folds of CASV
GP2 to other viral glycoprotein fusion subunits, we
examined the global backbone RMSD values of the
ectodomain segments using the SuperPose server
[43]. The pII (GCN4) segments for pII-GP fusions
were omitted from the RMSD calculation. The overall
backbone conformation of the CASV GP2 trimer is
extremely similar to the backbone from both MARV
and EBOV GP2 (RMSD values of 0.69 Å with MARV
CASV-GP2                                         RMSD:
MARV-GP2 (PDB ID 4G2K)
EBOV-GP2 (PDB ID 1EBO)               0.75 Å 
MoMLV-GP2 (PDB ID 1MOF)             0.50 Å 
LCMV-GP2 (PDB ID 3MKO)               4.20 Å 
(a) (d)(c)(b)
   0.69 Å 
Fig. 10. CASV GP2 Post-Fusion Bundle Structural Alignment. Global alignments of CASV GP2 with MARV GP2 (a,
PDB ID 4G2K), EBOV GP2 (b, PDB ID 1EBO), MoMLV TM (c, PDB ID 1MOF), and LCMV GP2 (d, PDB ID 3MKO). The pII
GCN4 segments have been shown in lighter colors (a and b) or omitted from the CASV GP2 structure (c and d). RMSD
calculations were performed excluding the pII GCN4 segments for CASV, EBOV, and MARV GP2.
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This striking similarity is somewhat surprising, given
that the sequences share b26% identity (Table 4).
The backbone conformation of CASV GP2 also
displays marked similarity to the fusion protein from
MoMLV, a retrovirus that causes cancer in some
murine hosts. The structure that is available for the
MoMLV fusion protein (TM) is truncated before the
CHR α-helical segments [34]; however, the trimeric
NHR coiled-coil core of MoMLV aligns well with the
CASV GP2 helical core (RMSD = 0.50 Å) with partic-
ular similarity observed in the membrane-proximal half
of the bundle, including the loop region (Fig. 10). TheTable 4. Sequence alignment of viral glycoprotein
transmembrane subunits with CASV GP2
Sequence alignment of viral glycoprotein transmembrane subunits
to CASV GP2
Virus % Identity % Similarity
GGV 80 92
Boa Av NL B3 79 92
EBOV 26 45
SUDV 25 42
MARV 28 46
LCMV 13 24
LASV 14 27CASV,MARV andEBOVGP2 structures all contained
the pII (GCN4) trimerization motif. Although this
segment was not included in the alignment, it should
nonetheless be considered whether it is in part
responsible for the similarity among these three
GP2s. None of the pII fusion structures contain
long-range interactions between GP2 segments and
pII. Furthermore, two structures of EBOV GP2 exist,
one containing the pII fusion and one without, and the
EBOV GP2 segments are in strong agreement with
one another and both the MARV and CASV segments
[3,15,30]. Therefore, these structures likely represent
the native GP2 post-fusion conformations.
Interestingly, however, global alignment of the
CASV and LCMV GP2 post-fusion structures results
in a high RMSD (4.20 Å; Fig. 10). The packing of the
CHR segments relative to the NHR core trimers
differs dramatically, and the loop region connecting
the NHR and CHR segments is significantly differ-
ent. Nonetheless, despite the low sequence homol-
ogy (13%; Table 4) and poor global structural
alignment, the architecture of CASV GP2 does
share some similar features with LCMV GP2. Both
structures contain a long core NHR trimer including
a heptad repeat stutter at similar locations (Fig. S1
of the Supplementary Data), an overall the
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ments and the presence ofmany potential salt bridges.
Additionally, the CASV GP2 and EBOV/MARV GP2
bundles display features that are remarkably similar to
those in the fusion proteins of other unrelated viruses,
such as the human T-lymphotropic virus type 1 GP21
and SARS (severe acute respiratory syndrome)
coronavirus S2 [44,45]. The conservation of the
general architecture of the fusion proteins across
these various viral families suggests that the structure
plays a crucial role in viral entry.
It has been previously hypothesized that arenavirus
and filovirus glycoproteins arose from a commonRNA
virus ancestor because of similarities in the overall
structure and amino-terminal residues [46]. The
evolutionary origin of the CASV family of viruses
remains unknown, but the similarity of CASVGP2with
EBOV and MARV GP2 raises the interesting possi-
bility that these viruses, or at least these glycoprotein
genes, do indeed share a common ancestor. It is
striking that the mechanism for pH dependence is
similar for both CASV and MARV GP2, involving an
anion stripe, but that the locations of participating
residues are not identical. Thus, the specific interac-
tions giving rise to pH-dependent behavior in these
two cases may have resulted from independent
co-evolution or may be the result of a single, common
ancestor. Either way, the results presented here
demonstrate that the GP2 structural architecture and
pH-dependent stability of the post-fusion state are
critical to function across multiple viruses.
Materials and Methods
Expression, purification and refolding of the CASV
GP2 constructs
Synthetic DNA fragments encoding “CASV-GP2(254–
351)” and “pIICASV-GP2(267–351)” (described in Results)
were obtained from a commercial supplier (Genewiz,
South Plainfield, NJ). The genes were cloned into
pET22b vectors (Novagen, Madison, WI) using NdeI and
XhoI restriction sites, producing the expression plasmids
pJFK3 and pJFK4, respectively. pJFK3 and pJFK4 were
transformed into E. coli BL21(DE3) cells (Invitrogen,
Carlsbad, CA) at 42 °C. These cells were grown in 1 l
cultures of 2× YT or LB broth at 37 °C to an OD600 of ~0.6.
Protein expression was then induced by the addition of
1 mM isopropyl-β-D-1-thiogalactopyranoside. The culture
was incubated at 37 °C while shaking at 220 rpm for an
additional 14–18 h. The cells were harvested by centrifu-
gation and lysed in 6 M guanidine hydrochloride (GdnHCl)
for 1–2 h at room temperature. The cell debris was
pelleted by ultracentrifugation, and the supernatant was
incubated with Ni-NTA resin (Qiagen, Valencia, CA) for
1–2 h at room temperature. The resin was washed with 10
column volumes of 6 M GdnHCl in phosphate-buffered
saline (PBS) containing 50 mM imidazole. The proteins
CASV-GP2(254–351) and pIICASV-GP2(254–351) were
eluted with 6 M GdnHCl in PBS containing 250 mMimidazole. The second purification step was performed
on the eluted protein by reverse-phase high-performance
liquid chromatography on a Vydac (Hesperia, CA) C18
column (10 μM, 250 mm × 21.2 mm) with water/trifluoroa-
cetic acid and acetonitrilemobile phases. The collected pure
protein fractions were combined and lyophilized, then
redissolved in 10 ml of 6 M GdnHCl in PBS. The proteins
were refolded by stepwise dialysis into 100 mM glycine
(pH 3.5) with 1 mM tris(2-carboxyethyl)phosphine (~4 h),
followed by dialysis into 10 mM sodium acetate [pH 4.1 and
pH 5.3 for CASV-GP2(254–351) and pIICASV-GP2(254–
351), respectively] (~18 h). The protein yield from 10 l of
cultures was ~0.3 mg and ~4.0 mg for CASV-GP2(254–
351) and pIICASV-GP2(254–351), respectively.
CD spectroscopy
CD measurements were performed on a Jasco J-815
spectrometer with a 1-cm quartz cuvette for the thermal
denaturation experiments and a 0.1-cm quartz cuvette for
the chemical denaturation experiments. Protein concen-
trations for CD ranged from 1.2 to 3.6 μM, as determined
by the absorbance at 280 nm. Full-wavelength scans were
obtained with a 1-nm step size and a 2-s averaging time and
represent the average of three scans. The signal was
converted to mean molar ellipticity (θ) using the equation: θ
(deg cm2 dmol−1) = (millidegrees × mean residue weight)/
(pathlength inmillimeters × protein concentration inmilligrams
per milliliter), where the mean residue weight is the molecular
weight divided by the number of backbone amides.
Thermal denaturation was monitored at 222 nm (θ222).
Protein samples were added to the appropriate buffer
(10 mM sodium acetate in PBS; pH 4.1, 4.8, 5.3, 5.8, 6.0 or
6.5) in a 1-cm-pathlength quartz cuvette and equilibrated for
5 min before beginning measurements at 15 °C. The
sample was stirred constantly as the temperature was
increased and data points were collected every 3–5 °C after
equilibration for ~2 min at each temperature. θ222 was
plotted as a function of temperature and converted to
fraction unfolded (FUNF) using the following equation:FUNF =
(θ222 − θUNF)/(θFOL − θUNF), where θUNF and θFOL are the
CD signals for the unfolded and folded states, respectively.
Glutaraldehyde cross-linking
The cross-linking reaction was initiated by mixing
purified CASV-GP2(254–315) and 25% glutaraldehyde
(Sigma-Aldrich, St. Louis, MO) stock solutions to final
concentrations of 0.15 mg/ml protein and 0.01% glutaral-
dehyde in 10 mM sodium acetate and 50 mM NaCl
(pH 5.3). The reaction was quenched at 0, 5, 15, 30, 60,
90 and 120 min with reducing SDS sample buffer. The
quenched samples were immediately boiled at 100 °C for
~5 min before being separated by SDS-PAGE.Crystallization
CASV-GP2(254–351) and pIICASV-GP2(267–351)
were concentrated to ~3.0 mg/ml in 10 mM sodium
acetate (pH 4.1 and 5.3, respectively). The constructs
were screened for crystallization using MCSG screening
kits (Microlytic, Burlington, MA) in 96-well sitting-drop
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best diffraction were grown in MCSG4-D10 [0.2 M lithium
sulfate, 0.1 M Mes (4-morpholineethanesulfonic acid)-
NaOH (pH 6.0) and 35% methyl-2,4-pentanediol]. The
crystals were mounted in cryo-loops directly from the
crystallization droplet and flash-cooled in liquid nitrogen.
Diffraction data were collected on a Rayonix 225 HE CCD
detector (Rayonix LLC, Evanston, IL) with 0.979 Å
wavelength radiation on the Lilly Research Laboratories
Collaborative Access Team beamline (Advanced Photon
Source, Illinois). Intensities were integrated using the
HKL2000 program and reduced to amplitudes using the
SCALEPACK2MTZ program [47,48].
The structure of pIICASV-GP2(267–351) was determined
by molecular replacement with PHASER [49]. The MARV
GP2 post-fusion structure (PDB ID 4G2K) was used as a
molecular replacement model [30]. Model building and
refinement were performed with the programs Coot and
REFMAC [47,50]. Stereochemistry was checked with the
program MolProbity [51]. LSQKAB and SSM algorithms
were used for structural superpositions [47,52]. Structural
figures were prepared using PyMOL (Schrödinger, LLC).
Virus production assays
JK cells were cultured as described previously [4]. JK
cells were plated in 12-well plates at a density of 100,000
per well. After 1 day of incubation, media in wells was
replaced with media containing 100 nM bafilomycin A1
(Tocris Bioscience, Bristol, United Kingdom) or 10 μM
monensin (Sigma-Aldrich). After 1 h of drug treatment,
clarified virus stocks were added to wells at a multiplicity of
infection of ~1/40. Six hours post-inoculation, media was
replaced with drug-free media. Supernatant was replaced
2 days post-infection. Supernatant was collected 4 days
post-infection, clarified and stored at −80 °C until further
analysis.Fluorescent-focus assay
JK cells were seeded in 12-well plates at a density of
200,000 per well. After 1 day of incubation, media was
replaced with media containing 100 nM bafilomycin A1
(Tocris Bioscience). After 1 h of drug treatment, wells were
inoculated with 10-fold serial dilutions of GGV stocks.
Dilutions were prepared in serum-free modified Eagle's
medium with 25 mM Hepes (pH 7.4), from a culture
supernatant stock that had been clarified by centrifugation
at 10,000g for 1 min. After 3 h of incubation at 30 °C,
culture medium was replaced with complete media
supplemented with molten 0.75% low-melting point aga-
rose (Life Technologies, Carlsbad, CA). After 7 days of
incubation, overlays were removed and cells fixed in 4%
formaldehyde in PBS. Wells were washed 3 times for
5 min in PBS, then in 0.1% Triton X-100 in PBS twice, then
in PBST (PBS + 0.1% Tween-20). Cells were blocked by
incubating in PBST + 1% bovine serum albumin for
30 min at 20 °C, then incubated in anti-GGV-NP polyclon-
al antibody [4] diluted 1:2000 into blocking buffer for
30 min. Cells were washed 4 times in PBST, then
incubated in goat anti-rabbit secondary antibody (LI-COR
Biosciences, Lincoln, NE) diluted 1:5000 in blocking buffer,
then washed again as before. A final wash in PBS wasperformed before imaging wells on a LI-COR Odyssey
scanner.
Quantitative real-time PCR
RNA was extracted from culture supernatant using the
ZR Viral RNA kit (Zymo Research, Irvine, CA). Reverse
transcription of RNA was performed in 10 μl reactions
containing 1× reaction buffer, 10 mM DTT, 1 mM each
dNTP, 100 pmol random hexamer, 100 U of Superscript III
RT (Life Technologies) and 5 μl RNA template. cDNA was
diluted to 80 μM in 10 mM Tris (pH 7.5) and 0.1 mM
ethylenediaminetetraacetic acid. Quantitative PCR reac-
tions contained 5 μl diluted cDNA, 0.25 μM each primer,
10 mM Tris (pH 8.8), 50 mM KCl, 1.5 mM MgCl2, 0.2 mM
each dNTP, 5% glycerol, 0.08% NP-40, 0.05% Tween-20,
0.15 μl Taq DNA polymerase and 1× Sybr Green (Life
Technologies) in each 15 μl reaction. Primer sequences
were as follows (5′–3′): GGV-S MDS-554 (CGG
TGAATCCTAGTGAGGAG) and MDS-555 (CTACCTTG-
G A C C C A C T G G A A ) ; G G V - L : M D S - 5 3 2
(CGRCTCCACCGCCATT) and MDS-533 (GAGTGC-
TAGTGARGAAAGAGATCC); CASV-S MDS-556
(TTCGAAAGAAGCGCAGTGAT) and MDS-557
(GCCTCTTGGTGAAAATTCTGC); CASV-L MDS-548
(GGCACAAACAGCATTGGTATC) and MDS-549
(TTCATCAGTGAGAGAGACTCAAGTG). Thermocycling
conditions were 95 °C for 30 min followed by 40 cycles
of 95 °C for 10 min, 60 °C for 12 min and 72 °C for 12 min
on a Lightcycler 480 instrument (Roche, Indianapolis, IN).
Accession codes
The X-ray coordinates and structure factors for pII-
CASV-GP2(267–351) have been deposited in Protein
Data Bank IDs 4N21 and 4N23.Acknowledgements
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